83 related articles for article (PubMed ID: 11494966)
1. A community based study on intentions regarding predictive testing for hereditary breast cancer.
Welkenhuysen M; Evers-Kiebooms G; Decruyenaere M; Claes E; Denayer L
J Med Genet; 2001 Aug; 38(8):540-7. PubMed ID: 11494966
[No Abstract] [Full Text] [Related]
2. Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer.
Meiser B; Butow P; Barratt A; Suthers G; Smith M; Colley A; Thompson E; Tucker K
J Med Genet; 2000 Jun; 37(6):472-6. PubMed ID: 10928861
[No Abstract] [Full Text] [Related]
3. Comparison of motivations and concerns for genetic testing in hereditary colorectal and breast cancer syndromes.
Balmaña J; Stoffel EM; Emmons KM; Garber JE; Syngal S
J Med Genet; 2004 Apr; 41(4):e44. PubMed ID: 15060120
[No Abstract] [Full Text] [Related]
4. Breast Cancer Genetics Knowledge and Testing Intentions among Nigerian Professional Women.
Ngene SO; Adedokun B; Adejumo P; Olopade O
J Genet Couns; 2018 Aug; 27(4):863-873. PubMed ID: 29260484
[TBL] [Abstract][Full Text] [Related]
5. To test or not to test? Moderators of the relationship between risk perceptions and interest in predictive genetic testing.
Shiloh S; Ilan S
J Behav Med; 2005 Oct; 28(5):467-79. PubMed ID: 16195820
[TBL] [Abstract][Full Text] [Related]
6. Attitudes toward the genetic testing of children among adults in a Utah-based kindred tested for a BRCA1 mutation.
Hamann HA; Croyle RT; Venne VL; Baty BJ; Smith KR; Botkin JR
Am J Med Genet; 2000 May; 92(1):25-32. PubMed ID: 10797419
[TBL] [Abstract][Full Text] [Related]
7. Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer.
Hopwood P; Shenton A; Lalloo F; Evans DG; Howell A
J Med Genet; 2001 Feb; 38(2):139. PubMed ID: 11288719
[No Abstract] [Full Text] [Related]
8. Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.
Bruno M; Digennaro M; Tommasi S; Stea B; Danese T; Schittulli F; Paradiso A
Eur J Cancer Care (Engl); 2010 May; 19(3):360-8. PubMed ID: 19912305
[TBL] [Abstract][Full Text] [Related]
9. Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients.
Ngoi N; Lee SC; Hartman M; Khin LW; Wong A
Breast; 2013 Feb; 22(1):47-52. PubMed ID: 22560561
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer attitudes, knowledge, and screening behavior in women with and without a family history of breast cancer.
Hailey BJ; Carter CL; Burnett DR
Health Care Women Int; 2000 Dec; 21(8):701-15. PubMed ID: 11813762
[TBL] [Abstract][Full Text] [Related]
11. Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Bottorff JL; Ratner PA; Balneaves LG; Richardson CG; McCullum M; Hack T; Chalmers K; Buxton J
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):89-95. PubMed ID: 11815405
[TBL] [Abstract][Full Text] [Related]
12. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
[TBL] [Abstract][Full Text] [Related]
13. A family history of breast cancer: women's experiences from a theoretical perspective.
Rees G; Fry A; Cull A
Soc Sci Med; 2001 May; 52(9):1433-40. PubMed ID: 11286366
[TBL] [Abstract][Full Text] [Related]
14. Effects of individual and family functioning on interest in genetic testing.
Bowen DJ; Bourcier E; Press N; Lewis FM; Burke W
Community Genet; 2004; 7(1):25-32. PubMed ID: 15475668
[TBL] [Abstract][Full Text] [Related]
15. A literature review of the psychological impact of genetic testing on breast cancer patients.
Schlich-Bakker KJ; ten Kroode HF; Ausems MG
Patient Educ Couns; 2006 Jul; 62(1):13-20. PubMed ID: 16242293
[TBL] [Abstract][Full Text] [Related]
16. [Psychosocial aspects of predictive gene diagnosis in familial breast and ovarian carcinomas].
von der Groeben C; Neef K; Rohde A; Bodden-Heidrich R; Schmutzler RK
Dtsch Med Wochenschr; 1999 Mar; 124(12):361-2. PubMed ID: 10214370
[No Abstract] [Full Text] [Related]
17. Interest in BRCA1/2 testing in a primary care population.
Armstrong K; Weber B; Ubel PA; Guerra C; Schwartz JS
Prev Med; 2002 Jun; 34(6):590-5. PubMed ID: 12052018
[TBL] [Abstract][Full Text] [Related]
18. Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer.
de Wit AC; Meijers-Heijboer EJ; Tibben A; Frets PG; Klijn JG; Devilee P; Niermeijer MF
Lancet; 1994 Jul; 344(8916):197. PubMed ID: 7912795
[No Abstract] [Full Text] [Related]
19. [Psychosocial factors associated with genetic testing for certain hereditary types of neoplasms].
Franková V; Zidovská J; Krutílková V; Havlovicová M; Goetz P
Cas Lek Cesk; 2003; 142(10):599-602. PubMed ID: 14635423
[TBL] [Abstract][Full Text] [Related]
20. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
